Corvus Pharmaceuticals (CRVS) Stock Chart & Stock Price History $3.94 -3.45 (-46.68%) (As of 10:03 AM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Corvus Pharmaceuticals Stock Price Performance 5 Day Performance+0.14%1 Month Performance-11.39%3 Month Performance+34.85%6 Month Performance+295.19%Year-To-Date Performance+319.89%1 Year Performance+379.87% Receive CRVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Genesis leading the smart algo revolution? (Ad)I’m revealing an exciting breakthrough that can help trade the markets unlike anything you’ve ever seen before… Because with my BRAND NEW smart algo you’ll always have a constant stream of alerts firing off in your back pocket to choose from. Here’s why: It does all the heavy lifting for you… automatically. Stock Ticker, Entry Price, Profit Target, Stop Loss, and even an Individual Chart!You’ll want to see what I’ve put on this page right here CRVS Stock Chart for Wednesday, December, 18, 2024 CRVS Chart by TradingView Corvus Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/17/2024$6.90$7.39+7.10%$7.44$6.441.15 million shs$474.86 million12/16/2024$7.38$6.90-6.50%$7.39$6.881.19 million shs$443.37 million12/13/2024$8.08$7.38-8.66%$8.22$7.291.72 million shs$474.24 million12/12/2024$8.11$8.08-0.37%$8.33$7.96887,639 shs$519.20 million12/11/2024$8.02$8.11+1.12%$8.25$7.88933,565 shs$521.15 million12/10/2024$8.15$8.02-1.60%$8.49$7.98577,754 shs$515.37 million Get the Latest News and Ratings for CRVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/09/2024$8.26$8.15-1.33%$8.43$8.00444,790 shs$523.72 million12/06/2024$8.13$8.26+1.60%$8.49$7.98477,032 shs$530.79 million12/05/2024$8.03$8.13+1.25%$8.29$8.00545,895 shs$522.43 million12/04/2024$8.28$8.03-3.02%$8.36$8.01608,507 shs$515.98 million12/03/2024$8.25$8.28+0.36%$8.28$7.951.12 million shs$532.07 million12/02/2024$9.09$8.25-9.24%$9.16$8.20838,640 shs$530.15 million11/29/2024$9.42$9.09-3.50%$9.55$9.09321,732 shs$584.12 million11/28/2024$9.42$9.42$9.50$8.63392,554 shs$605.33 million11/27/2024$8.73$9.42+7.90%$9.50$8.63392,554 shs$605.33 million11/26/2024$8.93$8.73-2.24%$9.25$8.60393,896 shs$560.96 million11/25/2024$8.95$8.93-0.22%$9.35$8.87710,846 shs$573.84 million11/22/2024$9.01$8.95-0.67%$9.19$8.801.21 million shs$575.10 million11/21/2024$8.24$9.01+9.34%$9.05$8.04756,920 shs$578.98 million11/20/2024$8.40$8.24-1.90%$8.39$8.02551,941 shs$529.50 million11/19/2024$8.34$8.40+0.72%$8.61$8.16807,082 shs$539.78 million11/18/2024$8.19$8.34+1.83%$8.70$8.16636,972 shs$535.90 million Related Companies Mirum Pharmaceuticals Stock Price Chart Disc Medicine Stock Price Chart Harmony Biosciences Stock Price Chart Tarsus Pharmaceuticals Stock Price Chart Xencor Stock Price Chart Galapagos Stock Price Chart Arvinas Stock Price Chart NewAmsterdam Pharma Stock Price Chart Evotec Stock Price Chart Arcus Biosciences Stock Price Chart Receive CRVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRVS) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corvus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Corvus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
